Managing atrial fibrillation outcomes registry
Part of Brain & nervous system, Heart & circulation clinical trials.
This registry collects information on people with atrial fibrillation to understand how different treatments affect their health and quality of life over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with atrial fibrillation (AFib), which can be related to your heart valves or not.
- Your AFib must have been confirmed by a heart monitor test such as an ECG, rhythm strip, event monitor, Holter, or implantable loop recorder.
- You are 18 years or older.
- You are able to give your consent to join the study.
- You can visit the research clinic at least once a year for follow-up.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry study follows people with atrial fibrillation to learn which risk factors are linked to stroke or blood clots traveling through the body. Your information helps improve how doctors predict risk and choose prevention strategies.
This study is a real-world registry that collects health information from people who have atrial fibrillation and were treated with a heart surgery procedure called ablation. It may help doctors better understand outcomes and care for people with this condition.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
This study follows people after a procedure called catheter ablation to treat atrial fibrillation (an irregular heart rhythm). It aims to learn which factors help predict outcomes, so future care can be better tailored.
This trial is a registry that collects information from people who have confirmed atrial fibrillation (an irregular heartbeat). It helps researchers better understand how atrial fibrillation affects people and may support future studies and care improvements.
This study follows people with atrial fibrillation to see how well blood-thinning medications work and what outcomes they experience over time. It aims to improve treatment guidance for patients with this common heart rhythm condition.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.